Autres langues Vernalis

Actions

VER

Recherche biotechnologique et médicale

Temps Différé London S.E.			Varia. 5j.	Varia. 1 janv.
- ^GBX	-.--%		+0,65%	-29,32%

Autres langues

14/12/17	Vernalis : AGM Statement
14/12/17	Vernalis PLC: AGM Statement
13/12/17	Vernalis : enters into research collaboration with Daiichi Sankyo
13/12/17	Vernalis : + Daiichi Sankyo Enter Collaboration
06/12/17	Vernalis : and Servier Achieve Research Milestone in Third Oncology Collaboration
06/12/17	Vernalis : and Servier Achieve Research Milestone
12/09/17	Vernalis : Results Announcement for the year ended 30 June 2017
12/09/17	Vernalis plc: Results Announcement for the year ended 30 June 2017
07/08/17	Vernalis : hit by fresh U.S. setback for cough and cold drug
07/08/17	Vernalis PLC: FDA Issues Complete Response Letter on CCP-08 NDA
18/07/17	Vernalis PLC: Year-End Trading Update and Notice of Full Year Results
21/04/17	Vernalis : receives a $2 million milestone payment from one of its drug discovery collaborations
21/04/17	Vernalis : FDA Issues a Complete Response Letter on CCP-07 NDA
21/04/17	Vernalis PLC: FDA Issues a Complete Response Letter on CCP-07 NDA
29/03/17	Vernalis : Block listing Interim Review
06/03/17	Vernalis : and Servier enter into a new drug discovery collaboration strengthening their existing partnership
06/03/17	Vernalis : New drug discovery collaboration with Servier
21/02/17	Vernalis PLC: Unaudited Interim Results for the six months ended 31 December 2016
14/02/17	Vernalis : achieves a $3 million milestone payment from Corvus Pharmaceuticals Inc
30/01/17	Vernalis PLC: Notice of Results for Six Months Ended 31/12/2016
30/01/17	Vernalis : Notice of Results for the Six Months Ended 31 December 2016
21/12/16	Vernalis : FDA accepts CCP-08 NDA for full review
21/12/16	Vernalis PLC: FDA accepts CCP-08 NDA for full review
01/12/16	Vernalis plc: AGM Statement
24/10/16	Vernalis : Notice of Annual Report and AGM